Stephen Fowler Flatt - 27 Feb 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen Flatt
Issuer symbol
NHC
Transactions as of
27 Feb 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 16:29:21 UTC
Previous filing
25 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Flatt Stephen Fowler CEO, Director 100 VINE STREET, MURFREESBORO /s/ Stephen Flatt 03 Mar 2026 0001330766

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Award $0 +3,090 +5.2% $0.000000 62,237 27 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NHC Option to Purchase Common Stock 6,147 27 Feb 2026 Common Stock 6,147 $53.94 Direct
holding NHC Option to Purchase Common Stock 10,000 27 Feb 2026 Common Stock 10,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 18,000 27 Feb 2026 Common Stock 18,000 $90.62 Direct
holding NHC Option to Purchase Common Stock 20,000 27 Feb 2026 Common Stock 20,000 $157.13 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.